Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Construction and Evaluation of Reconstituted High Density Lipoprotein as Effective Transfection Agent for Mesenchymal Stem Cell Based Cancer Therapy

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: CHEN, Kerong (China Pharmaceutical University, Nanjing, China)
  • Co-author(s): Kerong Chen: Pharmaceutics, China Pharmaceutical University, Nanjing, China
    Min Li: Pharmaceutics, China Pharmaceutical University, Nanjing, China
    Wei Wang: Pharmaceutics, China Pharmaceutical University, Nanjing, China
  • Abstract:

    Backgrounds

    Genetically engineered mesenchymal stem cells (MSCs) as a non-viral gene delivery platform has been developed rapidly in cancer therapy owing to its excellent immunogenicity and specific tumor homing. However, high efficient and safe gene transfer into primary MSCs is preconditions to achieve antineoplastic protocols. Reconstituted..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses